Dan Meyer

Cofounder, CellChorus

Search every verified Dan Meyer interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Daniel Meyer, CEO and cofounder of CellChorus, has presented the company's work at multiple health science events between 2021 and 2024. In his talks, he described CellChorus as a dynamic single-cell analysis company that applies artificial intelligence and machine learning to evaluate immune cell function, such as movement, synapse formation, killing, and cytokine secretion, at single-cell resolution and high throughput. He stated that the platform generates thousands of videos per sample and uses computer vision to analyze them, allowing customers to filter for specific cell behaviors and link results to downstream transcriptional profiling. Meyer discussed applications of the platform in preclinical and clinical development, including a study published with Kite, MD Anderson, and others that associated migration and serial-killing of CAR T cells with complete response in patients. He also noted that CellChorus was running an early access lab and preparing to launch its product, with partnerships being pursued in areas such as CRO relationships, instrument imaging, and international distribution. In earlier appearances, he emphasized the limitations of bulk live cell imaging and the need for high-throughput, single-cell dynamic analysis, and mentioned plans to place the first instrument with a customer.